Cargando…
Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
Development of noninvasive treatments for erythroplasia of Queyrat, a carcinoma in situ, is expected. This case suggests topical imiquimod might be a candidate with regimens consisting of much longer duration of the treatment than for genital warts and the maintenance phase of the treatment course t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452465/ https://www.ncbi.nlm.nih.gov/pubmed/30997072 http://dx.doi.org/10.1002/ccr3.2076 |